The Safety and Efficacy of Terpene-enriched Cannabidiol (CBD) Oil in ADHD

Clinical trial NCT06542445 · RECRUITING

Trial details

NCT number: NCT06542445
Sponsor: Bazelet Nehushtan LtD.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder (ADHD)

Start date: 2024-08-22
Primary completion: 2026-08-22
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.